Description
The abstract reports cell-type specific differences in mitophagy kinetics but doesn’t explain the underlying mechanisms. Understanding these differences could reveal why astrocytes may be more resilient to mitochondrial dysfunction in neurodegeneration.
Gap type: unexplained_observation Source paper: Hexokinase 2 interacts with PINK1 to facilitate mitophagy in astrocytes and restrain inflammation-induced neurotoxicity. (2025, Cell reports, PMID:40531619)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:35.512595+00:00”, “resolution_summary”: “Resolved by hypothesis h-9923279def: PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifies PD (SNCA/αSyn) and AD (tau/Abeta) Pathology. Supporting evidence includes debate sess_SDA-2026-04-06-gap-pubmed-20260406-041439-5f43216e_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-9923279def”, “title”: “PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifies PD (SNCA/αSyn) and AD (tau/Abeta) Pathology”, “score”: 0.345, “reason”: “8 token overlaps; entity overlap: pink1, pink1-”, “analysis_id”: null, “target_gene”: “PINK1,PRKN,TREM2,STUB1,NDUFS7”, “target_pathway”: “Mitophagy / PINK1-Parkin pathway; Microglial innate immunity”, “disease”: “neurodegeneration”, “composite_score”: 0.78, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“30742114”, “33168089”, “36282767”, “39051473”, “39809929”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-041439-5f43216e_task_9aae8fc5”, “title”: “The abstract identifies dystrophic microglia as senescent cells in aged brains but doesn’t explain the underlying mechanisms. Understanding these pathways is critical since identifying factors that drive microglial aging could delay neurodegenerative disease onset.\n\nGap type: unexplained_observation\nSource paper: Beyond Activation: Characterizing Microglial Functional Phenotypes. (2021, Cells, PMID:34571885)”, “score”: 0.435, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041439-5f43216e”, “quality_score”: 0.794, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7_task_73907230”, “title”: “The abstract mentions multiple organelles synchronously present structural derangement in diseases like neurodegeneration, but doesn’t explain how mitophagy, reticulophagy, and other selective autophagy processes coordinate. Understanding this coordination is critical for therapeutic targeting.\n\nGap type: unexplained_observation\nSource paper: Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. (2021, Autophagy, PMID:32048886)”, “score”: 0.434, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7”, “quality_score”: 0.8, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183021-c13d9f04”, “title”: “The abstract describes astrocyte phenotypic heterogeneity (A1/A2) but doesn’t explain the mechanistic switches governing this critical fate decision. Understanding these mechanisms is essential for therapeutic targeting of beneficial vs harmful astrocyte responses.\n\nGap type: unexplained_observation\nSource paper: Contribution of astrocytes to neuropathology of neurodegenerative diseases. (2021, Brain research, PMID:33516810)”, “score”: 0.429, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183021-c13d9f04”, “quality_score”: 0.66, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819”, “title”: “The abstract identifies APOE4’s primary effect on oligodendrocyte cholesterol metabolism but doesn’t explain the mechanistic pathway. Understanding this mechanism is critical for developing targeted therapeutics that address the root cause rather than downstream effects.\n\nGap type: unexplained_observation\nSource paper: APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes (2022, Nature, PMID:34788101)”, “score”: 0.415, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193244-89904941”, “quality_score”: 0.69, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a_task_73907230”, “title”: “The study shows P2RY12 regulates VSMC foam cell formation but doesn’t explain what controls P2RY12 expression or activation in VSMCs during disease progression. Understanding these upstream regulators could reveal new therapeutic targets for vascular neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)”, “score”: 0.41, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a”, “quality_score”: 0.661, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}